Metagenomi Therapeutics (MGX) Stock Price & Financial Analysis
Metagenomi Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Metagenomi Therapeutics
What is the current stock price for MGX?
As of the latest trading session, MGX stock trades at $1.35. The 52-week range is $1.23–$3.95, with a day range of $1.27–$1.37.
What is the P/E ratio for MGX?
The P/E ratio (Price-to-Earnings) for MGX is shown in the Key Statistics section. This valuation metric helps compare Metagenomi Therapeutics, Inc. to industry peers.
Does MGX pay dividends?
Metagenomi Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MGX?
Analyst ratings and recommendations for MGX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MGX?
Metagenomi Therapeutics's market capitalization is $50.3M, classifying it as a micro-cap company. Metagenomi Therapeutics operates in the Healthcare sector within the Biotechnology industry.